These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 20980520)

  • 1. Persistent Friend virus replication and disease in Apobec3-deficient mice expressing functional B-cell-activating factor receptor.
    Santiago ML; Smith DS; Barrett BS; Montano M; Benitez RL; Pelanda R; Hasenkrug KJ; Greene WC
    J Virol; 2011 Jan; 85(1):189-99. PubMed ID: 20980520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of viremia and production of neutralizing antibodies differentially regulated by polymorphic APOBEC3 and BAFF-R loci in friend virus-infected mice.
    Tsuji-Kawahara S; Chikaishi T; Takeda E; Kato M; Kinoshita S; Kajiwara E; Takamura S; Miyazawa M
    J Virol; 2010 Jun; 84(12):6082-95. PubMed ID: 20375169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection.
    Santiago ML; Montano M; Benitez R; Messer RJ; Yonemoto W; Chesebro B; Hasenkrug KJ; Greene WC
    Science; 2008 Sep; 321(5894):1343-6. PubMed ID: 18772436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mouse APOBEC3 restricts friend leukemia virus infection and pathogenesis in vivo.
    Takeda E; Tsuji-Kawahara S; Sakamoto M; Langlois MA; Neuberger MS; Rada C; Miyazawa M
    J Virol; 2008 Nov; 82(22):10998-1008. PubMed ID: 18786991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate retroviral restriction by Apobec3 promotes antibody affinity maturation in vivo.
    Santiago ML; Benitez RL; Montano M; Hasenkrug KJ; Greene WC
    J Immunol; 2010 Jul; 185(2):1114-23. PubMed ID: 20566830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fv1 restriction and retrovirus vaccine immunity in Apobec3-deficient 129P2 mice.
    Halemano K; Barrett BS; Li SX; Harper MS; Smith DS; Heilman KJ; Santiago ML
    PLoS One; 2013; 8(3):e60500. PubMed ID: 23533681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon signaling is required for the APOBEC3/Rfv3-dependent neutralizing antibody response but not innate retrovirus restriction.
    Barrett BS; Harper MS; Jones ST; Guo K; Heilman KJ; Kedl RM; Hasenkrug KJ; Santiago ML
    Retrovirology; 2017 Apr; 14(1):25. PubMed ID: 28415995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noninfectious retrovirus particles drive the APOBEC3/Rfv3 dependent neutralizing antibody response.
    Smith DS; Guo K; Barrett BS; Heilman KJ; Evans LH; Hasenkrug KJ; Greene WC; Santiago ML
    PLoS Pathog; 2011 Oct; 7(10):e1002284. PubMed ID: 21998583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoglobulin somatic hypermutation by APOBEC3/Rfv3 during retroviral infection.
    Halemano K; Guo K; Heilman KJ; Barrett BS; Smith DS; Hasenkrug KJ; Santiago ML
    Proc Natl Acad Sci U S A; 2014 May; 111(21):7759-64. PubMed ID: 24821801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reassessment of murine APOBEC1 as a retrovirus restriction factor in vivo.
    Barrett BS; Guo K; Harper MS; Li SX; Heilman KJ; Davidson NO; Santiago ML
    Virology; 2014 Nov; 468-470():601-608. PubMed ID: 25303118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement for Fc effector mechanisms in the APOBEC3/Rfv3-dependent neutralizing antibody response.
    Halemano K; Barrett BS; Heilman KJ; Morrison TE; Santiago ML
    J Virol; 2015 Apr; 89(7):4011-4. PubMed ID: 25589647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IFN-α treatment inhibits acute Friend retrovirus replication primarily through the antiviral effector molecule Apobec3.
    Harper MS; Barrett BS; Smith DS; Li SX; Gibbert K; Dittmer U; Hasenkrug KJ; Santiago ML
    J Immunol; 2013 Feb; 190(4):1583-90. PubMed ID: 23315078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tetherin/BST-2 promotes dendritic cell activation and function during acute retrovirus infection.
    Li SX; Barrett BS; Guo K; Kassiotis G; Hasenkrug KJ; Dittmer U; Gibbert K; Santiago ML
    Sci Rep; 2016 Feb; 6():20425. PubMed ID: 26846717
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fine mapping of the friend retrovirus resistance gene, Rfv3, on mouse chromosome 15.
    Super HJ; Hasenkrug KJ; Simmons S; Brooks DM; Konzek R; Sarge KD; Morimoto RI; Jenkins NA; Gilbert DJ; Copeland NG; Frankel W; Chesebro B
    J Virol; 1999 Sep; 73(9):7848-52. PubMed ID: 10438878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine Leukemia Virus P50 Protein Counteracts APOBEC3 by Blocking Its Packaging.
    Zhao W; Akkawi C; Mougel M; Ross SR
    J Virol; 2020 Aug; 94(18):. PubMed ID: 32641479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of murine APOBEC3 alleles in different mouse strains and their effect on mouse mammary tumor virus infection.
    Okeoma CM; Petersen J; Ross SR
    J Virol; 2009 Apr; 83(7):3029-38. PubMed ID: 19153233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apobec-mediated retroviral hypermutation in vivo is dependent on mouse strain.
    Byun H; Singh GB; Xu WK; Das P; Reyes A; Battenhouse A; Wylie DC; Santiago ML; Lozano MM; Dudley JP
    PLoS Pathog; 2024 Aug; 20(8):e1012505. PubMed ID: 39208378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deaminase-Dead Mouse APOBEC3 Is an
    Stavrou S; Zhao W; Blouch K; Ross SR
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29593034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome mapping of Rfv3, a host resistance gene to Friend murine retrovirus.
    Hasenkrug KJ; Valenzuela A; Letts VA; Nishio J; Chesebro B; Frankel WN
    J Virol; 1995 Apr; 69(4):2617-20. PubMed ID: 7884913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic regulation of long-term nonprogression in E-55+ murine leukemia virus infection in mice.
    Panoutsakopoulou V; Hunter K; Sieck TG; Blankenhorn EP; Blank KJ
    J Virol; 1999 Nov; 73(11):9232-6. PubMed ID: 10516031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.